Last week, the Lung Time Amwell CEO, Roy Schoenberg, announced, at the New England Journal of Medicine, not less, that he was building a companion for the elderly called Aileen. We immerse ourselves in the game state for digital health, what happened in Amwell and what is the goal for AI’s partner. They are the first days, but Roy has an interesting idea about how AI will work in the future to be the underlying platform to administer the experience of older consumers. Always a great conversation with Roy and this is no exceptionMatthew Holt
